Edition:
United Kingdom

Alkem Laboratories Ltd (ALKE.NS)

ALKE.NS on National Stock Exchange of India

2,105.70INR
9:59am GMT
Change (% chg)

Rs-21.70 (-1.02%)
Prev Close
Rs2,127.40
Open
Rs2,100.00
Day's High
Rs2,130.00
Day's Low
Rs2,084.90
Volume
30,432
Avg. Vol
34,396
52-wk High
Rs2,400.00
52-wk Low
Rs1,519.00

Chart for

About

Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The Company operates through two segments: pharmaceutical and investing. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and... (more)

Overall

Beta: --
Market Cap(Mil.): Rs221,380.59
Shares Outstanding(Mil.): 119.57
Dividend: 9.00
Yield (%): 0.81

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Alkem Labs Seeks Shareholders' Nod To Appoint Sandeep Singh As MD

* SEEKS SHAREHOLDERS' NOD TO RE-APPOINT DHANANJAY KUMAR SINGH AS JOINT MD Source text - http://bit.ly/2jn04KA Further company coverage:

07 Dec 2017

BRIEF-India's Alkem Labs Sept-qtr consol profit rises

* Sept quarter consol profit 3.27 billion rupees versus 2.88 billion rupees year ago

10 Nov 2017

BRIEF-India's Alkem Laboratories CEO Prabhat Agrawal resigns

Oct 31 Alkem Laboratories Ltd * Says Prabhat Agrawal resigns as CEO Source text - http://bit.ly/2xDyT3e Further company coverage:

31 Oct 2017

BRIEF-Alkem Labs re-designates ‍Sandeep Singh as MD

* ‍sandeep Singh appointed and re-designated as managing director​

17 Oct 2017

BRIEF-Alkem laboratories gets inspection report from US FDA with two 483 observations

* Says has received inspection report which contains two 483 observations

18 Sep 2017

BRIEF-India's Alkem Laboratories June-qtr consol net profit falls

* June quarter consol net profit 637.8 million rupees versus profit of 2.43 billion rupees year ago

11 Aug 2017

Earnings vs. Estimates